Short Interest in Click Holdings Limited (NASDAQ:CLIK) Rises By 3,422.4%

Click Holdings Limited (NASDAQ:CLIK) was the recipient of a significant increase in short interest during the month of March. As of March 31st, there was short interest totaling 15,886 shares, an increase of 3,422.4% from the March 15th total of 451 shares. Based on an average daily trading volume, of 370,894 shares, the short-interest ratio is currently 0.0 days. Approximately 1.4% of the company’s stock are sold short.

Click Trading Down 20.6%

Click stock traded down $0.71 during trading on Friday, hitting $2.74. 542,578 shares of the company were exchanged, compared to its average volume of 713,307. The business’s 50 day moving average is $3.05 and its 200 day moving average is $5.33. Click has a 52 week low of $1.32 and a 52 week high of $95.70.

Analysts Set New Price Targets

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of Click in a report on Friday, March 27th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, Click presently has an average rating of “Sell”.

About Click

Click Therapeutics, Inc (NASDAQ: CLIK) is a clinical-stage digital therapeutics company developing software-based treatments for neurological, psychiatric and chronic diseases. Its platform delivers prescription digital therapies via mobile and web applications, combining evidence-based cognitive behavioral interventions, digital monitoring tools and patient engagement techniques. Click’s approach is designed to complement or extend traditional pharmacological and behavioral treatments for conditions such as major depressive disorder, insomnia and tobacco use disorder.

Founded in 2014, Click has progressed multiple programs through randomized controlled trials and regulatory review.